Health risks related to polyurethane foam degradation in CPAP devices used for sleep apnoea treatment

Patients with PUF-CPAP and especially those with pre-existing obstructive lung disease had increased use of anti-obstructive medication but there were no differences in hospitalisations and mortality, and data on cancer were inconclusive https://bit.ly/3uVIzXG

Detalles Bibliográficos
Autores principales: Palm, Andreas, Grote, Ludger, Ekström, Magnus, Ljunggren, Mirjam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Agora
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117731/
https://www.ncbi.nlm.nih.gov/pubmed/35144995
http://dx.doi.org/10.1183/13993003.00237-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117731/
https://www.ncbi.nlm.nih.gov/pubmed/35144995
http://dx.doi.org/10.1183/13993003.00237-2022

Ejemplares similares